跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,600 条关于
“FAP-Exd”
全部
8,600
临床试验
7,445
药物
600
机构
31
资讯
524
前天
Avacta Reports Clinical Proof of Mechanism for FAP-Activated Exatecan PDC AVA6103 in Phase 1 FOCUS-01
11个月前
Avacta Develops First Dual-Payload Peptide Drug Conjugate Platform for Cancer Combination Therapy
7个月前
Avacta Therapeutics Promotes Francis Wilson to Chief Scientific Officer to Lead pre|CISION Platform Development
11个月前
NUCLIDIUM Secures US Patent Protection for Copper-Based FAP-Targeting Radiotheranostics Platform
去年
Telix Pharmaceuticals Expands Radiopharmaceutical Portfolio with Strategic FAP-Targeting Acquisition
去年
Recursion's REC-4881 Shows 30% Polyp Reduction in FAP Patients in Phase 1b/2 Trial
前天
Perspective Therapeutics, Merck Partner to Test [212Pb]PSV359 Plus Keytruda in FAP-α-Positive Solid Tumors
去年
Avacta to Present Updated Phase 1a Data for FAP-Targeted Doxorubicin Conjugate AVA6000 at ESMO 2025
去年
Precirix Receives FDA Clearance to Begin Phase 1 Trial of CAM-FAP-Ac-225 Targeted Alpha Therapy
3个月前
Short-Term Postoperative Outcomes Comparable Between IRA and IPAA in FAP, Cleveland Clinic Study Finds
第 1 页,共 53 页
上一页
下一页